Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001254625 | SCV001430652 | likely benign | Interstitial lung disease due to ABCA3 deficiency | 2020-06-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002069350 | SCV002433710 | likely benign | not provided | 2024-07-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327607 | SCV002638918 | uncertain significance | Hereditary pulmonary alveolar proteinosis | 2014-08-05 | criteria provided, single submitter | clinical testing | The c.447+8G>A intronic variant results from a G to A substitution 8 nucleotides after coding exon 3 in the ABCA3 gene. Based on data from the NHLBI Exome Sequencing Project (ESP), the A-allele has an overall frequency of approximately 0.02% (3/12,980), having been observed in 0.07% (3/4388) of African American alleles and in none of 8592 European American alleles. This nucleotide position is not conserved on limited sequence alignment, and the A-allele is present in zebra finch. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on the native splice donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Prevention |
RCV003973166 | SCV004794941 | likely benign | ABCA3-related disorder | 2020-10-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |